Greg Calaman, Senior Partner

Greg Calaman is a Senior Partner of The Lucas Group and is a leader in the firm’s Private Equity practice. Greg brings 360-degree insight cultivated through roles in management consulting, board-level strategy, and general management in companies ranging from the Fortune 50 to venture-backed start-ups. His reputation as a trusted advisor crosses many industries with especially deep perspective in the healthcare, technology, and finance sectors.

Prior to TLG, Greg served as Head of North America for VC-backed, Nobel Laureate-founded software company Definiens AG where he drove sales, set strategy, and built a winning culture. At Pfizer, he reported to the C-level and led deployment of $200M in investment capital against high-ROI, internal IT opportunities, contributing to a near $1B rise in EBITDA.

Greg also founded and ran iArmor, a pioneering health-tech company created to monetize continuous physiological information on at-risk outpatients. Greg was recruited to build a high-growth services unit at BEA Systems (c/k/a Oracle) where he exceeded targets and led efforts that accelerated BEA’s growth. At Computer Sciences Corporation, he worked with life sciences and consumer products clients on transformation activities. At Donaldson Lufkin & Jenrette (c/k/a Credit Suisse), Greg led a strategic function that deployed technologies to drive competitive advantage, including Wall Street’s first all-digital trading floor. As a commissioned officer in the US Navy, Greg served in several leadership roles.

Greg holds a BS in Aerospace/Astro Engineering from the US Naval Academy and was sponsored by BEA to attend a Wharton Executive Education program. He served on advisory boards at Drexel University and the Trestle Group Foundation.